U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Cipro (Ciprofloxacin Hydrochloride)
for Inhalation Anthrax


Cipro (ciprofloxacin hydrochloride) is an antibiotic used to treat bacterial infections in many different parts of the body. It does not work for viral infections (for example, the common cold). Cipro is approved for the inhaled form of anthrax after an individual has been exposed.  Safety and effectiveness in pediatric patients and adolescents less than 18 years of age have not been established, except for use in inhalational anthrax (post-exposure).  

For more information about Cipro, please contact the Division of Drug Information at druginfo@cder.fda.gov or 1-888-INFOFDA (463-6332).

totop.gif (1525 bytes) Back to Top   Back Back to Drug Information


FDA/Center for Drug Evaluation and Research
Last Updated: November 14, 2001
Originator: OTCOM/DLIS
HTML by SJW; CSA